Poor
Not Aligned
Patient Risk:
Low
Summary
All provided claims concern pricing/copay/OOP estimates and insurance coverage from non-label sources. These details are absent from the FDA-approved prescribing information supplied for evaluation, so the response lacks label support and is non-compliant with label-based accuracy requirements.
Category Scores
Accurate Statements
Unsupported Statements
The cost of KEYTRUDA can range from around $12,500 to over $14,000 per infusion, according to the official Merck website.
Pricing/cost-per-infusion figures are absent from the label provided for evaluation.
The cited KEYTRUDA cost figures do not include additional costs such as doctor visits, hospital stays, or copays.
Definitions/exclusions of included costs are absent from the label provided for evaluation.
Out-of-pocket (OOP) expenses for KEYTRUDA can range from $500 to $3,500 per month depending on individual insurance coverage and copayment plans, according to a study published by 2022.
OOP estimates from external studies are absent from the label provided for evaluation.
The average monthly OOP expense for KEYTRUDA was reported to be around $1,600, according to a study from 2021.
OOP estimates from external studies are absent from the label provided for evaluation.
For patients with commercial insurance, the copay for KEYTRUDA can vary depending on the specific insurance plan.
Copay variability by insurer/plan is absent from the label provided for evaluation.
Some commercial insurance plans may cover up to 75% of the medication cost of KEYTRUDA, according to DrugPatentWatch.com.
Insurance coverage percentages by insurer are absent from the label provided for evaluation.
Some commercial insurance plans may cover 50% or less of the medication cost of KEYTRUDA, according to DrugPatentWatch.com.
Insurance coverage percentages by insurer are absent from the label provided for evaluation.
Under various commercial insurance plans, the listed copayment range for KEYTRUDA for Aetna is $500-$1,500, according to DrugPatentWatch.com.
Insurer-specific copayment ranges are absent from the label provided for evaluation.
Under various commercial insurance plans, the listed copayment range for KEYTRUDA for Cigna is $500-$1,000, according to DrugPatentWatch.com.
Insurer-specific copayment ranges are absent from the label provided for evaluation.
Under various commercial insurance plans, the listed copayment range for KEYTRUDA for UnitedHealthcare is $750-$2,500, according to DrugPatentWatch.com.
Insurer-specific copayment ranges are absent from the label provided for evaluation.
Copay costs for KEYTRUDA may be subject to change.
Statements about changing copays are absent from the label provided for evaluation.
Contradictions
Important Omissions
Any label-supported safety/clinical labeling content (e.g., boxed warnings, contraindications, warnings/precautions, dosing safety, monitoring) relevant to a comprehensive prescribing-information alignment check.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The claims evaluated are financial/insurance-related and do not describe clinical dosing/safety actions. However, the lack of label support may mislead users about prescribing-information-backed content.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Not Aligned
Primary Issue
All substantive claims are about costs/copays/OOP and insurer coverage, which are absent from the FDA-approved prescribing information provided for evaluation.
Suggested Improvement
Remove or clearly segregate non-label financial/insurance estimates from the label-aligned prescribing-information summary, and rely only on label-supported clinical/safety content when presenting FDA labeling information.